Wade Schulz to Spike Glycoprotein, Coronavirus
This is a "connection" page, showing publications Wade Schulz has written about Spike Glycoprotein, Coronavirus.
Connection Strength
0.053
-
Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection. J Appl Lab Med. 2021 07 07; 6(4):1005-1011.
Score: 0.026
-
Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 07; 27(7):1178-1186.
Score: 0.026